MDisrupt, an Austin, TX-based marketplace for the health-tech industry, has raised $3 million in seed funding. The round was led by The Venture Collective, with participation from Capita3, 3plus VC, Geek Ventures, Mindshift Capital, The BFM Fund, Zane Venture Fund, Emmeline Ventures, Growth Factory, and other strategic investors in the healthcare and technology sectors. In conjunction with the funding, Cat Middleton, General Partner at The Venture Collective (TVC), is joining the MDisrupt Board of Directors.
MDisrupt is a marketplace that connects health tech and life science companies with health experts to help them build, commercialize, and scale their health products. With over 1,500 experts from Blue Cross Blue Shield, CVS, Willis Towers Watson, U.S. FDA, Optum, and Cleveland Clinic, the company serves companies across health-tech and life science sectors including startups and enterprises.
The health-tech industry is booming, with global spending on health-tech products and services expected to reach $600 billion by 2025. This growth is being driven by a number of factors, including the rising prevalence of chronic diseases, the aging population, and the increasing adoption of technology in healthcare.
MDisrupt is well-positioned to capitalize on this growth. The company’s marketplace provides a one-stop shop for health tech and life science companies to find the experts they need to bring their products to market.
Health-Tech Marketplace Startups
Other health-tech marketplaces that have recently raised funding include:
- Clarify Health (US): Raised $100 million in Series D funding in June 2023. Clarify Health is a healthcare data analytics company that provides insights to help healthcare providers and payers improve patient care and reduce costs.
- Health Catalyst (US): Raised $100 million in Series E funding in May 2023. Health Catalyst is a healthcare data analytics and transformation company that helps healthcare providers and payers improve patient care and reduce costs.
- Symphony Health (US): Raised $300 million in Series F funding in April 2023. Symphony Health is a healthcare data analytics and market intelligence company that provides insights to help healthcare providers, payers, and life sciences companies make better business decisions.
These startups are all developing innovative solutions to address the challenges of the healthcare industry. However, they are also facing increasing competition from each other and from established players in the healthcare sector.
Deal Table for MDISRUPT
| Key People | Investors | Amount Invested | Sector | Funding Round |
|---|---|---|---|---|
| Ruby Gadelrab (Founder and CEO) | The Venture Collective | $3 million | Health-tech | Seed |